Aviva
NVCR icon

Aviva’s NovoCure NVCR Stock Holding History

Aviva’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-87,041
Closed -$3.61M – 1004
2023
Q2 		$3.61M Sell
87,041
-115,318
-57% -$7.16M 0.01% 554
2023
Q1 		$12.2M Buy
202,359
+1,929
+1% +$154K 0.06% 435
2022
Q4 		$14.7M Buy
200,430
+120,871
+152% +$9.09M 0.07% 373
2022
Q3 		$6.04M Sell
79,559
-29,516
-27% -$2.3M 0.03% 538
2022
Q2 		$7.58M Buy
109,075
+82,524
+311% +$6.22M 0.04% 499
2022
Q1 		$2.2M Sell
26,551
-3,931
-13% -$290K 0.01% 807
2021
Q4 		$2.29M Sell
30,482
-802
-3% -$80.5K 0.01% 844
2021
Q3 		$3.63M Sell
31,284
-7,546
-19% -$1.14M 0.02% 661
2021
Q2 		$8.61M Sell
38,830
-4,842
-11% -$942K 0.04% 433
2021
Q1 		$5.77M Buy
43,672
+29,930
+218% +$4.73M 0.03% 492
2020
Q4 		$2.38M Sell
13,742
-8,154
-37% -$1.12M 0.01% 646
2020
Q3 		$2.44M Sell
21,896
-17,685
-45% -$1.41M 0.01% 611
2020
Q2 		$2.35M Sell
39,581
-14,476
-27% -$952K 0.01% 618
2020
Q1 		$3.64M Buy
+54,057
New +$4.27M 0.03% 565

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Aviva's NVCR Position: Q3 2023 in Review

Aviva sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 87,041 shares — an estimated $3.61M sold.

Aviva first reported a position in NVCR in Q1 2020 and held it in 14 quarters. The position peaked at $14.7M in Q4 2022. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Aviva reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Aviva sold 87,041 NovoCure shares in Q3 2023, an estimated $3.61M.
  • Aviva first reported a position in NovoCure in Q1 2020 and held it in 14 quarters.
  • Aviva's NovoCure position peaked at $14.7M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Aviva's 13F filing for Q3 2023, filed 13 Nov 2023.